Q1 2026 · 13F-HR
Vitruvian Partners LLPholdings as filed
Filed 2026-05-11 · accession 0001420506-26-000881
$111.8M
Reported value
7
Positions
2026-03-31
Period end
The Brief · Vitruvian Partners LLP · Q1 2026
AI · grounded in 13F
Vitruvian Partners LLP reported no changes to its 13F holdings for 2026-03-31 relative to 2025-12-31.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 433313103 | HNGE | HINGE HEALTH INC | $48.2M | 43.1% | 1,250,000 | Common | SOLE |
| 57142B104 | MQ | MARQETA | $28.0M | 25.0% | 6,853,183 | Common | SOLE |
| 141788109 | CARG | CARGURUS INC | $16.1M | 14.4% | 472,959 | Common | SOLE |
| 98423F109 | XMTR | XOMETRY INC | $7.8M | 7.01% | 191,919 | Common | SOLE |
| M5216V106 | GLBE | GLOBAL-E | $6.5M | 5.80% | 210,209 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE | $3.5M | 3.17% | 5,043,356 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT | $1.7M | 1.54% | 278,865 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.